Search for: "MERCK SHARP "
Results 181 - 200
of 262
Sorted by Relevance
|
Sort by Date
22 May 2019, 4:10 am
” This blog’s analysis of Monday’s opinion in Merck Sharp & Dohme v. [read post]
16 May 2023, 7:33 am
See Merck Sharp & Dohme Corp. v. [read post]
24 May 2019, 3:10 am
” At Michael Best, James Lawrence III and Joseph Olson look at this week’s decision in Merck Sharp & Dohme v. [read post]
16 May 2023, 7:33 am
See Merck Sharp & Dohme Corp. v. [read post]
23 Aug 2012, 7:00 am
Investopedia.com defines it as follows: A colloquialism to denote the potential sharp decline in revenues upon patent expiry of one or more leading products of a firm. [read post]
28 Mar 2023, 4:46 am
In November 2020, the BRPTO rejected without further administrative appeal a patent application filed by Merck Sharp & Dohme (MSD) on January 8, 2009, after the applicant failed to respond to an office action and later to appeal the decision rejecting the application. [read post]
20 May 2019, 7:43 am
In Merck Sharp & Dohme Corp. v. [read post]
23 Aug 2012, 7:00 am
Investopedia.com defines it as follows: A colloquialism to denote the potential sharp decline in revenues upon patent expiry of one or more leading products of a firm. [read post]
28 Nov 2018, 2:01 pm
Merck Sharp & Dohme Corp. v. [read post]
28 Jun 2010, 3:08 am
Paranova Danmark A/S, Paranova Pack A/S v Merck Sharp & Dohme Corp. [read post]
27 Jun 2010, 6:00 pm
Paranova Danmark A/S, Paranova Pack A/S v Merck Sharp & Dohme Corp. [read post]
21 Nov 2012, 5:00 am
Merck Sharp & Dohme Corp., 807 N.W.2d 343, 347 (Mich. [read post]
27 Dec 2022, 4:33 pm
Merck Sharp & Dohme (C-119/22) made by the Finnish Market Court in February 2022 (see here for an English translation of the referring decision) and Merck Sharp & Dohme v. [read post]
28 Oct 2021, 6:06 am
The importance of proving CGK was highlighted in a recent IP High Court case (Merck Sharp & Dohme Corp. v. [read post]
28 Oct 2021, 6:06 am
The importance of proving CGK was highlighted in a recent IP High Court case (Merck Sharp & Dohme Corp. v. [read post]
18 May 2011, 12:33 am
Merck (EPLAW) Byetta, Bydureon (Exenatide) – US: Amylin files suit against Eli Lilly alleging anticompetitive activity and breach of strategic alliance agreements (GenericsWeb) Copegus (Ribavarin) – Portugal: Lisbon Court of Appeal accepts registration for CORIÉGUS for dietetic substance – CORIÉGUS v. [read post]
15 Oct 2018, 12:52 am
The Court of Appeal clarified in Merck v Merck Sharpe & Dohme [2017] EWCA Civ 1834. that this targeting should be considered on an objective basis. [read post]
14 Aug 2023, 5:03 am
(I will have to go away and read Merck Sharp & Dohme Corp v Merck KGaA (2021) 1 SLR 1102 properly.) [read post]
16 Dec 2016, 4:44 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in… [read post]
26 Aug 2019, 12:09 pm
Supreme Court in the next term.Africa Correspondent Chijioke Okorie reports on Raconteur Productions Limited v Dioni VisionsEntertainment Limited and 2 Others, heard before the Lagos Division of the Federal High Court of Nigeria, concerning the possibility of copyright infringement of a ‘screenplay’, which is not specifically mentioned or defined in the Nigerian Copyright Act as a protected work.Platform Liability -Former GuestKat Mirko Brüß examines another case referred… [read post]
